ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBaselFerrosa Therapeutics AG
Ferrosa Therapeutics AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Ferrosa Therapeutics AG develops next-generation biologics for anemia of inflammation, with applications in chronic kidney disease, cancer, and autoimmune diseases. The company is advancing a bispecific antibody lead program in the discovery stage.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.5/5

Ferrosa Therapeutics AG

✓ Offered2
Bispecific Antibody Development
Development of next-generation biologics using a bispecific antibody to treat anemia of inflammation, focused on preclinical research and target validation.
Therapies for Anemia of Inflammation
Therapies for anemia of inflammation in chronic kidney disease, cancer, and autoimmune disorders, with a focus on long-term treatment and subcutaneous administration.
Trust & reputation

ranQ Trust Score of Ferrosa Therapeutics AG: 3.5 out of 5.0

Trust Score3.5/ 5.0

Solid

x

Data basis 54% · As of October 2026

Ferrosa Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Ferrosa Therapeutics AG scores 42.7 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.0.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Ferrosa Therapeutics AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Ferrosa Therapeutics AG scores 8.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.8.94%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Ferrosa Therapeutics AG reaches a ranQ Trust Score of 3.5 out of 5.0 — rated «Solid». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Ferrosa Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Ferrosa Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Ferrosa Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Ferrosa Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Hier entsteht die Karte
Aeschenvorstadt 48
4051 Basel

At a glance

Legal form
Corporation
UID
CHE-459.489.255
Founded
2026 · 0 years
Last commercial register change
March 6, 2026
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    IS
    Immunovant Sciences GmbH
    Basel
    AS
    Autolus Switzerland AG
    Basel
    WB
    Windward Bio Group AG
    Basel
    WB
    Windward Bio 27 AG
    Basel
    VT
    Vaderis Therapeutics AG
    Basel
    NA
    NBE-Therapeutics AG
    Basel
    RS
    Regeneron Switzerland GmbH
    Basel
    CT
    ClearideBio Therapeutics AG
    Basel